March 5, 2014
Health Minister Norihisa Tamura said on March 4 that the ministry will conduct hearings with Takeda Pharmaceutical over clinical data it used to promote the hypertension drug Blopress (candesartan). “We’ll conduct hearings with Takeda to determine whether data issues existed,”...read more